Review:
Dpp 4 Inhibitors
overall review score: 4.2
⭐⭐⭐⭐⭐
score is between 0 and 5
DPP-4 inhibitors, also known as dipeptidyl peptidase-4 inhibitors, are a class of oral medications used to manage type 2 diabetes. They work by inhibiting the enzyme DPP-4, which results in increased levels of incretin hormones such as GLP-1. This enhances insulin secretion and decreases glucagon production, thereby helping to lower blood glucose levels in individuals with diabetes.
Key Features
- Oral administration
- Mechanism of action involves inhibition of DPP-4 enzyme
- Increases incretin hormone levels to promote insulin secretion
- Generally well-tolerated with a favorable side effect profile
- Often used as monotherapy or in combination with other antidiabetic agents
- Minimal risk of hypoglycemia compared to some other diabetes medications
Pros
- Effective at lowering blood glucose levels
- Convenient oral dosing schedule
- Low risk of hypoglycemia when used alone
- Well-tolerated with few serious side effects
- Suitable for patients with varying degrees of renal function (with dose adjustments)
Cons
- May cause nasopharyngitis or headache in some patients
- Not usually sufficient as monotherapy for all patients; often used in combination therapy
- Potential for weight neutrality or slight weight gain
- Rarely associated with pancreatitis or allergies
- Cost may be higher compared to some older medications